Literature DB >> 11746021

Secular trends in congenital anomaly-related fetal and infant mortality in Canada, 1985-1996.

S Liu1, K S Joseph, S W Wen, M S Kramer, S Marcoux, A Ohlsson, R Sauve.   

Abstract

Prenatal diagnosis of major congenital anomalies and subsequent termination of affected pregnancies has been widely available as part of routine obstetric care in recent years. In this study, vital statistical data on stillbirths, live births, and infant deaths were used to examine secular trends in gestational age-specific and category-specific fetal and infant mortality due to congenital anomalies in Canada (excluding Ontario and Newfoundland) from 1985-1996. Comparisons of the rates between 1985-1987 and 1994-1996 were made using relative risks and 95% confidence intervals (CI). The overall fetal mortality rate due to congenital anomalies increased significantly, from 68.0 per 100,000 total births in 1985-1987 to 78.6 per 100,000 total births in 1994-1996, while the overall infant mortality rate due to congenital anomalies decreased significantly over the same period, from 2.47 to 1.79 per 1,000 live births. The fetal death rate due to congenital anomalies at 20-21 weeks of gestation increased approximately five-fold (relative risk [RR] = 4.83, 95% CI = 3.28-7.11) from 4.5 to 21.5 per 100,000 fetuses at risk, while the rate at 37-41 weeks decreased by 30% (RR = 0.70, 95% CI = 0.50-0.97). Fetal death rates among pregnancies at 20-25 weeks of gestation increased in all categories of congenital anomaly except anencephaly and respiratory system anomalies. Congenital anomaly-related fetal and infant deaths have increased at early gestation but declined at later gestation in Canada. These changes suggest an increase in prenatal diagnosis and selective termination of pregnancies with congenital anomalies in recent years. Copyright 2001 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2001        PMID: 11746021

Source DB:  PubMed          Journal:  Am J Med Genet        ISSN: 0148-7299


  9 in total

1.  Changes in maternal characteristics in Nova Scotia, Canada from 1988 to 2001.

Authors:  Deshayne B Fell; K S Joseph; Linda Dodds; Alexander C Allen; Krista Jangaard; Michiel Van den Hof
Journal:  Can J Public Health       Date:  2005 May-Jun

2.  [Not Available].

Authors: 
Journal:  Paediatr Child Health       Date:  2005-07       Impact factor: 2.253

3.  Use of anencephalic newborns as organ donors.

Authors: 
Journal:  Paediatr Child Health       Date:  2005-07       Impact factor: 2.253

4.  Impact of pre-pregnancy diabetes mellitus on congenital anomalies, Canada, 2002-2012.

Authors:  S Liu; J Rouleau; J A León; R Sauve; K S Joseph; J G Ray
Journal:  Health Promot Chronic Dis Prev Can       Date:  2015-07       Impact factor: 3.240

5.  Neonatal and infant mortality associated with spina bifida: A systematic review and meta-analysis.

Authors:  Peter Ho; Maria A Quigley; Dharamveer Tatwavedi; Carl Britto; Jennifer J Kurinczuk
Journal:  PLoS One       Date:  2021-05-12       Impact factor: 3.240

6.  Birth weight differences between preterm stillbirths and live births: analysis of population-based studies from the U.S. and Sweden.

Authors:  Xun Zhang; K S Joseph; Sven Cnattingius; Michael S Kramer
Journal:  BMC Pregnancy Childbirth       Date:  2012-10-30       Impact factor: 3.007

7.  A parsimonious explanation for intersecting perinatal mortality curves: understanding the effect of plurality and of parity.

Authors:  KS Joseph; Shiliang Liu; Kitaw Demissie; Shi Wu Wen; Robert W Platt; Cande V Ananth; Susie Dzakpasu; Reg Sauve; Alexander C Allen; Michael S Kramer
Journal:  BMC Pregnancy Childbirth       Date:  2003-06-02       Impact factor: 3.007

8.  A parsimonious explanation for intersecting perinatal mortality curves: understanding the effects of race and of maternal smoking.

Authors:  K S Joseph; Kitaw Demissie; Robert W Platt; Cande V Ananth; Brian J McCarthy; Michael S Kramer
Journal:  BMC Pregnancy Childbirth       Date:  2004-04-16       Impact factor: 3.007

9.  Effect of Folic Acid Food Fortification in Canada on Congenital Heart Disease Subtypes.

Authors:  Shiliang Liu; K S Joseph; Wei Luo; Juan Andrés León; Sarka Lisonkova; Michiel Van den Hof; Jane Evans; Ken Lim; Julian Little; Reg Sauve; Michael S Kramer
Journal:  Circulation       Date:  2016-08-30       Impact factor: 29.690

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.